Future work will examine how AR and its signaling exhibits the cell-specific effects within prostate tumors and how this affects interactions between cancer cells and immune cells in the tumor microenvironment to produce differential responses to AR-targeted therapies. This evidence concerns the gene AR and neoplasm.